ArticleFrontiers in nutrition2025
Association of dietary index for gut microbiota and cardiovascular diseases in American adults: evidence from National Health and Nutrition Examination Survey 1999-2018.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As a significant health burden, cardiovascular disease (CVD) contributes substantially to global disease and death rates. While the gut microbiota has been linked to CVD, its dietary influence remains unclear. The Dietary index for gut microbiota (DI-GM) evaluates diet-related impacts on microbiota diversity. This study explores the relationship between DI-GM and the risk of CVD. Methods: Using National Health and Nutrition Examination Survey (NHANES) data spanning 1999-2018, this cross-sectional study included 39,181 adults aged 20 years or older, among whom were individuals with CVD. DI-GM, based on dietary recall, was calculated to assess microbiota diversity. Multivariable weighted logistic regression explored the association between DI-GM and CVD, with trend tests, subgroup analyses, smoothed curves, and multiple imputation ensuring robustness. Mediation analysis examined the role of body mass index (BMI). Results: A total of 39,181 participants (mean age: 47.15 years) were included, with 49.18% female and 50.82% male. Higher DI-GM levels correlated with a decreased prevalence of CVD (DI-GM: OR = 0.95, 95% CI = 0.92-0.98). Compared to participants with DI-GM scores of 0-3, those with DI-GM ≥6 had significantly lower CVD risk (OR = 0.82, 95% CI = 0.71-0.94). Restricted cubic spline analysis showed a linear association between DI-GM and CVD. A significant mediating effect of BMI was observed (proportion of mediation: 16.27%, 95% CI: 9.11%-35.48%). Conclusions: An inverse association was found between the DI-GM index and CVD prevalence, where increased DI-GM scores corresponded to a lower CVD risk, partly mediated by reductions in BMI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.